HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Smoking cessation should be ‘pillar’ of the cancer treatment protocol Jennifer R. Southall
-
- Are e-cigarettes a viable tool to help patients with cancer quit smoking?
- The administration beats cancer Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- Promoting APP professionalism in hematopoietic stem cell transplantation Misty D. Evans, DNP, APRN, CPNP-AC, BMTCN®
- ‘Surprising’ link between ibrutinib, hypertension spurs further study Jennifer Byrne
- Sociodemographic factors may influence survival among young adults with colorectal cancer Jennifer R. Southall
- Gut bacteria may be factor in rising colorectal cancer incidence among younger adults John DeRosier
- Neoadjuvant pembrolizumab benefits patients with high-risk triple-negative breast cancer Mark Leiser
- Genetic alterations at diagnosis predict transplant outcomes for older patients with AML Mark Leiser
-
- Fragmentation of care common among young adults with sickle cell disease Drew Amorosi
- Cancer mortality rate drops 29% between 1991 and 2017 John DeRosier
- Hyperbaric oxygen therapy safe, effective for treating symptoms of late radiation cystitis John DeRosier
- UM171-expanded cord blood safe for certain adults with hematologic malignancies Jennifer R. Southall
- Omega-3 supplementation fails to reduce risk for colorectal cancer precursors John DeRosier
- FDA approves Xtandi for metastatic castration-sensitive prostate cancer
- FDA approves Keytruda for bladder cancer subset
- FDA grants orphan drug designation to HSB-1216 for small cell lung cancer
-
- FDA grants priority review to Lynparza as part of ovarian cancer maintenance regimen
- ASH presents Scholar Awards to fellows, junior faculty
- Fred Hutchinson Cancer Research Center names new president, director